Citation Impact
Citing Papers
Complement and microglia mediate early synapse loss in Alzheimer mouse models
2016 StandoutScience
α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro
2010 StandoutScienceNobel
Parkinson-like syndrome induced by continuous MPTP infusion: Convergent roles of the ubiquitin-proteasome system and α-synuclein
2005 StandoutNobel
Tau: Enabler of diverse brain disorders and target of rapidly evolving therapeutic strategies
2021 Science
Alzheimer's disease: synapses gone cold
2011
Alzheimer's disease: synaptic dysfunction and Aβ
2009
The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia
2010
Amyloid beta: structure, biology and structure-based therapeutic development
2017
Synapses and Alzheimer's Disease
2012 StandoutNobel
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
Searching for new pharmacological targets for the treatment of Alzheimer's disease in Down syndrome
2017
Recent advances in our understanding of neurodegeneration
2009
Affibody-Mediated Sequestration of Amyloid β Demonstrates Preventive Efficacy in a Transgenic Alzheimer’s Disease Mouse Model
2019
The Amyloid-β Pathway in Alzheimer’s Disease
2021
Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - too little activation is bad, too much is even worse
2007
Alzheimer Mechanisms and Therapeutic Strategies
2012
Amyloid Triggers Extensive Cerebral Angiogenesis Causing Blood Brain Barrier Permeability and Hypervascularity in Alzheimer's Disease
2011
Biochemical and immunohistochemical analysis of an Alzheimer's disease mouse model reveals the presence of multiple cerebral Aβ assembly forms throughout life
2009
Channel opening and gating mechanism in AMPA-subtype glutamate receptors
2017 StandoutNatureNobel
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
2006 Standout
The role of autophagy in neurodegenerative disease
2013 Standout
Silent synapses and the emergence of a postsynaptic mechanism for LTP
2008
Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy
2012 Standout
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
2019 Standout
Monomeric Aβ1–42 and RAGE: key players in neuronal differentiation
2014
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
2007 Standout
Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging
2013 Standout
Presynaptic Neurexin-3 Alternative Splicing trans-Synaptically Controls Postsynaptic AMPA Receptor Trafficking
2013 StandoutNobel
Classification and basic pathology of Alzheimer disease
2009
Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
2010
Cognitive deficits in a mouse model of pre‐manifest Parkinson’s disease
2012
Cilostazol Use Is Associated with Reduced Risk of Dementia: A Nationwide Cohort Study
2017
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
2017 Standout
LTP Requires a Unique Postsynaptic SNARE Fusion Machinery
2013 StandoutNobel
Immunotherapeutic Approaches for Alzheimer’s Disease
2015
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
2015 Standout
Immune attack: the role of inflammation in Alzheimer disease
2015 Standout
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
2011 StandoutNature
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease
2019
Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer’s disease
2018
Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease
2008
Annotation of functional variation in personal genomes using RegulomeDB
2012 Standout
Parkinson's disease
2015 Standout
Drug repurposing: progress, challenges and recommendations
2018 Standout
Molecular pathophysiology of impaired glucose metabolism, mitochondrial dysfunction, and oxidative DNA damage in Alzheimer's disease brain
2016
ADDLs and the signaling web that leads to Alzheimer’s disease
2010
α-Synuclein Cooperates with CSPα in Preventing Neurodegeneration
2005 StandoutNobel
Animal Models of Alzheimer Disease
2012
Alzheimer's Disease Brain-Derived Amyloid-β-Mediated Inhibition of LTPIn VivoIs Prevented by Immunotargeting Cellular Prion Protein
2011
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Neurotoxicity of Amyloid -Protein: Synaptic and Network Dysfunction
2012
Resolving controversies on the path to Alzheimer's therapeutics
2011
Non-motor features of Parkinson disease
2017 Standout
The Amyloid State of Proteins in Human Diseases
2012 Standout
Design of amyloidogenic peptide traps
2024 StandoutNobel
Small vessel disease: mechanisms and clinical implications
2019 Standout
Nerve Growth Factor and Alzheimer's Disease: New Facts for an Old Hypothesis
2012
Linking pathways in the developing and aging brain with neurodegeneration
2014
Heavy-Chain Complementarity-Determining Regions Determine Conformation Selectivity of Anti-Aβ Antibodies
2010
Amyloid‐β Oligomers: Possible Roles as Key Neurotoxins in Alzheimer's Disease
2010
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
2012 Standout
Structural Bases of Desensitization in AMPA Receptor-Auxiliary Subunit Complexes
2017 StandoutNobel
Retrograde dopaminergic neuron degeneration following intrastriatal proteasome inhibition
2005
Intracellular amyloid-β in Alzheimer's disease
2007 Standout
Ubiquitin Hydrolase Uch-L1 Rescues β-Amyloid-Induced Decreases in Synaptic Function and Contextual Memory
2006
Activity Patterns Govern Synapse-Specific AMPA Receptor Trafficking between Deliverable and Synaptic Pools
2009
The amyloid state and its association with protein misfolding diseases
2014 Standout
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
2013 Standout
AMPA Receptor Incorporation into Synapses during LTP: The Role of Lateral Movement and Exocytosis
2009
A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer’s disease
2015
The Monomer State of Beta-Amyloid: Where the Alzheimer's Disease Protein Meets Physiology
2010
Biliverdin Reductase-A Mediates the Beneficial Effects of Intranasal Insulin in Alzheimer Disease
2018
GluN2B subunit-containing NMDA receptor antagonists prevent Aβ-mediated synaptic plasticity disruption in vivo
2009
The amyloid hypothesis of Alzheimer's disease at 25 years
2016 Standout
Ligand-Gated Ion Channels: New Insights into Neurological Disorders and Ligand Recognition
2012
Elucidation of AMPA receptor–stargazin complexes by cryo–electron microscopy
2016 StandoutScienceNobel
Lecanemab in Early Alzheimer’s Disease
2022 Standout
Native α-synuclein induces clustering of synaptic-vesicle mimics via binding to phospholipids and synaptobrevin-2/VAMP2
2013 StandoutNobel
Postsynaptic GluA1 enables acute retrograde enhancement of presynaptic function to coordinate adaptation to synaptic inactivity
2010
KEGG: integrating viruses and cellular organisms
2020 Standout
Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ) deposition
2010
Diabetic Cardiomyopathy
2018 Standout
Microglia Function in the Central Nervous System During Health and Neurodegeneration
2017 Standout
Regulation of Caenorhabditis elegans neuronal polarity by heterochronic genes
2019 StandoutNobel
A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules
2015 Standout
The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies
2021 Standout
Double-knockout mice for α- and β-synucleins: Effect on synaptic functions
2004 StandoutNobel
How neuroinflammation contributes to neurodegeneration
2016 StandoutScience
Genetic reduction of Nrf2 exacerbates cognitive deficits in a mouse model of Alzheimer’s disease
2017
A monoclonal antibody against synthetic Aβ dimer assemblies neutralizes brain‐derived synaptic plasticity‐disrupting Aβ
2011
The Brain's Default Mode Network
2015 Standout
Transcription Factor CREM Mediates High Glucose Response in Cardiomyocytes and in a Male Mouse Model of Prolonged Hyperglycemia
2017
Intracellular metalloprotease activity controls intraneuronal Aβ aggregation and limits secretion of Aβ via exosomes
2018
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
2018 Standout
BACE inhibitors in clinical development for the treatment of Alzheimer’s disease
2018
Emerging Targets in Photopharmacology
2016 StandoutNobel
Works of Daniela Puzzo being referenced
Involvement of the Nitric Oxide Pathway in Synaptic Dysfunction Following Amyloid Elevation in Alzheimer's Disease
2006
A GluR1-cGKII Interaction Regulates AMPA Receptor Trafficking
2007
Cell Cultures From Animal Models of Alzheimer's Disease as a Tool for Faster Screening and Testing of Drug Efficacy
2004
A key role for TGF-β1 in hippocampal synaptic plasticity and memory
2015
Behavioral assays with mouse models of Alzheimer's disease: Practical considerations and guidelines
2014
Amyloid-β Peptide Is Needed for cGMP-Induced Long-Term Potentiation and Memory
2017
Intracellular Accumulation of Amyloid- (A ) Protein Plays a Major Role in A -Induced Alterations of Glutamatergic Synaptic Transmission and Plasticity
2014
Phosphodiesterase 5 Inhibition Improves Synaptic Function, Memory, and Amyloid- Load in an Alzheimer's Disease Mouse Model
2009
Fluoxetine and Vortioxetine Reverse Depressive-Like Phenotype and Memory Deficits Induced by Aβ1-42 Oligomers in Mice: A Key Role of Transforming Growth Factor-β1
2019
Rodent models for Alzheimer’s disease drug discovery
2015
Amyloid-β Peptide Inhibits Activation of the Nitric Oxide/cGMP/cAMP-Responsive Element-Binding Protein Pathway during Hippocampal Synaptic Plasticity
2005
Tau is not necessary for amyloid-β–induced synaptic and memory impairments
2020
Endogenous amyloid‐β is necessary for hippocampal synaptic plasticity and memory
2010
Neutralization of TNFSF10 ameliorates functional outcome in a murine model of Alzheimer’s disease
2014
Picomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus
2008
Fibrillar β-Amyloid Impairs the Late Phase of Long Term Potentiation
2006
The keystone of Alzheimer pathogenesis might be sought in Aβ physiology
2015
Alpha-synuclein: between synaptic function and dysfunction.
2003
Amyloid-β Peptide: Dr. Jekyll or Mr. Hyde?
2012